Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Laminar Pharmaceuticals

Clinical trials sponsored by Laminar Pharmaceuticals, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for kids with brain cancer? LAM561 trial launches Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New hope for kids with brain cancer? LAM561 trial launches

Disease control Recruiting now

This study tests an oral drug called LAM561 in children under 18 with advanced brain tumors (like high-grade glioma) or other solid tumors that have not responded to standard treatments. The trial has two phases: first, finding a safe dose in up to 18 children, then testing that …

Phase 1/2 • Sponsor: Laminar Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC